Glycosylation deficiency of lipopolysaccharide-binding protein and corticosteroid-binding globulin associated with activity and response to treatment for rheumatoid arthritis.

Ciregia, Federica;Baiwir, Dominique;Cobraiville, Gaël;Dewael, Thibaut;de Seny, Dominique;et.al.
(2020) Journal of Translational Medicine — Vol. 18, n° 1, p. 8 [1-17] (2020)

Files

2020_Ciregia_J_Transl_Med.pdf
  • Open Access
  • Adobe PDF
  • 2.06 MB
Download

Details

Authors
  • Ciregia, Federicaorcid-logo
    Author
  • Baiwir, Dominique
    Author
  • Cobraiville, Gaël
    Author
  • Dewael, Thibaut
    Author
  • Sokolova, TatianaUCLouvain
    Author
  • Durez, PatrickUCLouvain
    Author
  • de Seny, Dominique
    Author
Show more
Abstract
BACKGROUND: Serum protein glycosylation is an area of investigation in inflammatory arthritic disorders such as rheumatoid arthritis (RA). Indeed, some studies highlighted abnormalities of protein glycosylation in RA. Considering the numerous types of enzymes, monosaccharides and glycosidic linkages, glycosylation is one of the most complex post translational modifications. By this work, we started with a preliminary screening of glycoproteins in serum from RA patients and controls. METHODS: In order to isolate glycoproteins from serum, lectin wheat germ agglutinin was used and quantitative differences between patients and controls were investigated by LC-MS/MS. Consequently, we focused our attention on two glycoproteins found in this explorative phase: corticosteroid-binding globulin (CBG) and lipopolysaccharide-binding protein (LBP). The subsequent validation with immunoassays was widened to a larger number of early RA (ERA) patients (n = 90) and well-matched healthy controls (n = 90). RESULTS: We observed a significant reduction of CBG and LBP glycosylation in ERA patients compared with healthy controls. Further, after 12 months of treatment, glycosylated CBG and LBP levels increased both to values comparable to those of controls. In addition, these changes were correlated with clinical parameters. CONCLUSIONS: This study enables to observe that glycosylation changes of CBG and LBP are related to RA disease activity and its response to treatment.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Ciregia, F., Baiwir, D., Cobraiville, G., Dewael, T., Mazzucchelli, G., Badot, V., Di Romana, S., Sidiras, P., Sokolova, T., Durez, P., Malaise, M. G., & de Seny, D. (2020). Glycosylation deficiency of lipopolysaccharide-binding protein and corticosteroid-binding globulin associated with activity and response to treatment for rheumatoid arthritis. Journal of Translational Medicine, 18(1), 8 [1-17]. https://doi.org/10.1186/s12967-019-02188-9 (Original work published 2020)